Poly Hist

Poly Pharmaceuticals, Inc.
Great Southern Laboratories

Poly Hist CB

FULL PRESCRIBING INFORMATION: CONTENTS*

• POLY HIST CB
• Clinical Pharmacology:
• Indications And Usage:
• Contraindications:
• Warnings:
• Precautions:
• Carcinogenesis, Mutagenesis, And Impairment of Fertility:
• Pregnancy:
• Nursing Mothers:
• Side Effects:
• Overdosage:
• Dosage and Administration:
• How Supplied:
• PRODUCT PACKAGING:

FULL PRESCRIBING INFORMATION

POLY HIST CB

Clinical Pharmacology:

Indications And Usage:

Contraindications:

Warnings:

Precautions:

Carcinogenesis, Mutagenesis, And Impairment of Fertility:

Pregnancy:

Nursing Mothers:

Side Effects:

Overdosage:

Dosage and Administration:

How Supplied:

PRODUCT PACKAGING:

USUAL DOSAGE: Adults 12 years and older:
Children 6-12 years of age: Children 2-6 years of age:
Children under 2 years of age:



KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
IN CASE OF ACCIDENTAL OVERDOSAGE, CONTACT A POISON CONTROL
CENTER AND SEEK PROFESSIONAL ASSISTANCE IMMEDIATELY.





STORAGE: ^oooo

Mfg. for:

Mfg. by:

Poly Hist Carbetapentane Citrate, and Guaifenesin LIQUID Product Information Product Type Human prescription drug label Item Code (Source) NDC:50991-781 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Carbetapentane Citrate CARBETAPENTANE 20 mg Guaifenesin GUAIFENESIN 75 mg Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50991-781-16 473 in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date 2009-11-30